Bristol Myers Pfizer: Which High Yield Stock Wins Now?
Two pharma giants compete for your portfolio's income. This guide weighs yields, safety, and long-term risks to answe...
A snapshot of the year-to-date total market return for 2024, outlining performance drivers and practical implications for investors.
28,420 articlesTwo pharma giants compete for your portfolio's income. This guide weighs yields, safety, and long-term risks to answe...
In a surprise move, President Trump said he would not sign the housing bill until Congress passes a separate voter-id...
GameStop is weighing a bold move: acquiring eBay. This article breaks down whether does Gamestop's proposed acquisiti...
Friday's strong jobs data complicates the Fed's rate path, signaling higher borrowing costs ahead while raising quest...
A top Moody’s economist argues AI-related costs are propping up inflation, not damping it. He warns relief won’t arri...
Optimum (OPTU) is reshaping its strategy in 2026. This original analysis dives into the Q1 results, margins, and capi...
Dogecoin nudges higher near a major support zone as on-chain metrics show heavy demand. Could dogecoin (doge) setting...
As the nation marks its 250th birthday, Anthony Scaramucci urges a return to thrift and steady investing to protect h...
After years of warnings, Ray Dalio says the U.S. is entering a period of deep turbulence tied to its debt path, with ...
New CPI data renews tensions between Trump’s White House and Fed Chair Warsh, signaling a potential policy clash as i...
Inflation remains a challenge, but certain businesses have pricing power that helps them weather higher costs. This a...
The SPDR S&P Metals & Mining ETF (XME) has surged toward a near-double over the past year, buoyed by gold and copper ...